AbioMed
Sign in to saveAbiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
Company
- Industry
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Entity type
- operating
- Fiscal year end
- Mar 31
- Latest filing
- SC 13G/A · 2023-01-06
via SEC EDGAR
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1981
- Location
- Danvers, United States
- Status
- Active
GRID grid.281749.1 · ISNI 0000 0004 0415 9035
Described at
ABIOMED INC - Wikirate, an Open ESG Data Platform
wikirate.org →Link to a page describing this subject · 2,687 chars · not written by Vinony
~9 min read
Encyclopedic overview
6 sectionsContents
- History
- Technology
- Leadership
- See also
- References
- External links
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
Andrew Greenfield is President of the company, with Dr. Thorsten Siess as Executive Vice President and Chief Technology Officer and Dr. Chuck Simonton as Executive Vice President and Chief Medical Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients".
Excerpted from Wikipedia’s “AbioMed” article, available under the CC BY-SA 4.0 licence.